BioLineRx Ltd. (TLV:BLRX)
1.800
-0.100 (-5.26%)
Nov 6, 2025, 5:24 PM IDT
BioLineRx Employees
BioLineRx had 28 employees as of December 31, 2024. The number of employees decreased by 51 or -64.56% compared to the previous year.
Employees
28
Change (1Y)
-51
Growth (1Y)
-64.56%
Revenue / Employee
2.08M ILS
Profits / Employee
-941.24K ILS
Market Cap
46.99M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28 | -51 | -64.56% |
| Dec 31, 2023 | 79 | 30 | 61.22% |
| Dec 31, 2022 | 49 | 11 | 28.95% |
| Dec 31, 2021 | 38 | 0 | - |
| Dec 31, 2020 | 38 | -4 | -9.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Teva Pharmaceutical Industries | 35,686 |
| Danel (Adir Yeoshua) | 4,290 |
| Novolog (Pharm-Up 1966) | 936 |
| Kamada | 420 |
| InterCure | 320 |
| Bait Bakfar | 227 |
| Ilex Medical | 178 |
| SofWave Medical | 126 |
BioLineRx News
- 5 weeks ago - BioLineRx Ltd. (BLRX) Investor Call (Transcript) - Seeking Alpha
- 5 weeks ago - BioLineRx Ltd. - Special Call - Seeking Alpha
- 5 weeks ago - BioLineRx (BLRX) and Hemispherian Collaborate on Innovative Cancer Therapy - GuruFocus
- 5 weeks ago - BioLineRx Ltd. and Hemispherian AS Establish Joint Venture to Develop GLIX1, a First-in-Class, Oral, Small Molecule Targeting DNA Damage Response in Glioblastoma and Other Cancers - PRNewsWire
- 3 months ago - BioLineRx Ltd. (BLRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioLineRx GAAP EPS of $0.00, revenue of $5.39M - Seeking Alpha
- 3 months ago - BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 3 months ago - Earnings Scheduled For August 14, 2025 - Benzinga